Susan Kearney
Pediatric Hematology-Oncology · Minneapolis, MNNPI 1154375061
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (51.1%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Novo Nordisk AS at 52.6% of the total. Reporting peaked in 2019 at $10,798 and has fallen 99.0% since, to $112 in 2022.
Across 9 payments — averaging $2279.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk AS$11K
- Sanofi$5K
- Bioverativ Therapeutics Inc.$3K
- Genentech USA, Inc.$2K
- CSL Behring$112
Across 235 payments — averaging $1377.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$294K
- Bioverativ Therapeutics Inc.$13K
- Daiichi Sankyo Inc.$12K
- Sanofi US Services Inc.$2K
- Swedish Orphan Biovitrum AB$2K
- Grifols Therapeutics LLC$2K
- plus $750 from 1 others
What the payments were for
- Consulting fees$4,69323%
- Speaking & faculty fees$4,91424%
- Travel & lodging$10,47851%
- Food & beverage$4322%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk AS | 4 | $10,798 |
| Sanofi | 2 | $4,914 |
| Bioverativ Therapeutics Inc. | 1 | $2,958 |
| Genentech USA, Inc. | 1 | $1,735 |
| CSL Behring | 1 | $112 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$20,517 in reported general payments places this provider in the 80th percentile of 60 pediatric hematology-oncology providers in Minnesota.
See all pediatric hematology-oncology providers in Minnesota →
Other pediatric hematology-oncology in Minneapolis
- Bruce BlazarMinneapolis$1.1M
- Margaret MacmillanMinneapolis$143K
- Stephanie Fritch LillaMinneapolis$85K
- Heather StefanskiMinneapolis$67K
- Christopher MoertelMinneapolis$65K
- Troy LundMinneapolis$65K
- John WagnerMinneapolis$55K
- Paul OrchardMinneapolis$44K
- Stephen NelsonMinneapolis$15K
- Marie SteinerMinneapolis$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.